A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
Eli Lilly and Company
Eli Lilly and Company
St. Jude Children's Research Hospital
National Institutes of Health Clinical Center (CC)
Seattle Children's Hospital
Milton S. Hershey Medical Center
The University of Texas Health Science Center, Houston
Ipsen
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Ipsen
St. Jude Children's Research Hospital
Children's Oncology Group
Memorial Sloan Kettering Cancer Center
University of California, San Francisco
Masonic Cancer Center, University of Minnesota
St. Jude Children's Research Hospital
University of Alabama at Birmingham
Emory University
Florida International University
Pediatric Brain Tumor Consortium
Ann & Robert H Lurie Children's Hospital of Chicago
Emory University
Emory University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
Children's Oncology Group
National Cancer Institute (NCI)
London School of Hygiene and Tropical Medicine
National Cancer Institute (NCI)
Children's Oncology Group
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Pediatric Brain Tumor Consortium